Remote digital healthcare for patient monitoring and digital drug delivery has been a reality for some time, but it hasn’t gained much attention outside the medical field. That is, until the COVID-19 pandemic put a spotlight on the critical challenges of our changing world.
The notion of the “hype cycle” has haunted countless technologies in the past. First, new technologies and their infant products and solutions are lauded to the skies. Then, disillusionment sets in when delivery is delayed. And finally, cool appraisal wins the day. Perhaps no other technology has been so bound to the notion of a hype cycle than 5G. Sometimes, though, when people see the true potential of a new technology, excitement sets in that bit more readily, that bit more quickly, and it’s understandable that some impatience may creep in. And it’s no wonder. As 5G rides out an interim period where ongoing support for 3G/4G/LTE is still required and COVID stands as a significant delay tactic, the market is inevitably keen for 5G to be fully implemented, and now. The market needs it, it seems.